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Gastroesophageal reflux disease (GERD) is a common chronic disease of the gastrointes-
tinal tract that occurs in 3.1% of the Chinese population [1]. Heartburn, acid regurgitation
and epigastric pain are typical clinical symptoms of GERD. These symptoms can affect
patients' work productivity, sleep, diet and daily activities, thus resulting in a reduced
quality of life (QOL) [2]. Although patient QOL is increasingly being considered as a medical
outcome index in the evaluation of the impact of GERD symptoms on patients' health
status, measuring patient QOL in clinical trials can be challenging due to the lack of a
standard assessment tool. Therefore, we aim to review the commonly used generic,
disease-specific and hybrid QOL questionnaires to evaluate patients with GERD to provide a
reference for clinical nursing work.
Copyright © 2015, Chinese Nursing Association. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Generic quality of life (QOL) scales
frequently utilized to evaluate patients with
gastroesophageal reflux disease (GERD)
Generic assessment instruments canbebroadly applied across
various health conditions, with the purpose of investigating
the general health status of the subjects. Three different
generic scales exist that are extensively used in assessing the
QOL of GERD patients: the medical outcomes study 36-item
short-form health survey (SF-36), the psychological general
well-being index (PGWBI) and the EuroQol 5D (EQ-5D). The SF-ng).
Nursing Association.
Association. Production
://creativecommons.org/36 is one of themost widely used generic instruments, since it
contains only 36 items and has proven to be useful in evalu-
ating the clinical curative effect of GERD. It has been well
established that the various versions of the SF-36 have
acceptable psychometric properties, therefore these scales are
the gold standard in the validation of other QOL scales [1e3].
The SF-36 scale does have a somewhat poor sensitivity, so
scholars do prefer to combine it with disease-specific in-
struments in the assessment of a patient's health status [4].
The PGWBI is specifically designed to measure subjective
psychological well-being and depression in the general pop-
ulation. This scale has been confirmed to effectively measureand hosting by Elsevier (Singapore) Pte Ltd. This is an open access
licenses/by-nc-nd/4.0/).
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disease [5,6]. The limitation of the PGWBI is that its emphasis
is on the general well-being of patients rather than the
development of physiological functions and vitality. Although
the findings of Pace et al. [7] determined that the PGWBI is
effective in evaluating patients with GERD, further study is
needed to demonstrate the sensitivity and specificity of the
PGWBI.
Finally, the EQ-5D is an extensively used, multidimen-
sional scale that consists of two parts: the utility value and the
questionnaire. The questionnaire is well-documented in
terms of its reliability and validity in all available language
versions. In addition, it is able to be combined with other in-
struments to assess the current health status of patients with
GERD. The advantage of the EQ-5D scale is its ability to eval-
uate the cost-effectiveness of clinical interventions via con-
ducting utility value conversions. Therefore, the EQ-5D can
offer guidance to health care systems by suggesting clinical
therapeutic regimens. Grant and colleagues [8] have con-
ducted a five-year follow-up study of a randomized clinical
trial to discuss the long-term clinical effectiveness, cost-
effectiveness and safety of laparoscopic surgery among pa-
tients with GERDwho required long-termmedication, surgery
andmedical management. The results indicated that EQ-5D is
a reliable, feasible and validated instrument in the evaluation
of GERD patients.2. Disease-specific QOL scales oftentimes
used in the assessment of GERD patients
The scales discussed in this section have been developed
specifically for the evaluation of patients with GERD, and
therefore demonstrate high sensitivities and responsiveness.
One major advantage of these disease-specific scales is that
they can monitor small yet significant changes in patient
health. The following five questionnaires are the most com-
mon disease-specific scales used in clinical work today.
2.1. Health-related QOL scale for GERD (GERD-HRQL)
The GERD-HRQL was developed to survey symptomatic out-
comes and therapeutic effects in patients with GERD [9]. The
scale has 11 items, which focus on heartburn symptoms,
dysphagia,medication effects and the patient's present health
condition. The GERD-HRQL takes approximately one minute
to complete. Each item is scored from 0 to 5, with a higher
score indicating a better QOL. Velanovich et al. [9] examined
the psychometric properties of the GERD-HRQL in GERD pa-
tients within a clinical trial. They reported that the Cronbach's
a coefficient for each subscale ranged from 0.89 to 0.94, the
testeretest reliability resulted in an intra-class correlation
coefficient (ICC) of 0.93 and the responsiveness to clinical
change was acceptable. In China, Liu et al. [10] applied the
GERD-HRQL to evaluate the efficacy of the Stretta procedure
on GERD patients. The main evaluation indices were the
GERD-HRQL score, satisfaction of symptom control and
medication use. The results showed that there were signifi-
cant increases in QOL at six and twelve months after treat-
ment when compared to baseline (8.1 vs. 7.3 vs. 25.6,respectively; p < 0.01). Onset of relief of GERD symptoms was
observed less than two months (70.0%) and two to six months
(16.7%) post-treatment, and the percentage of patients with
satisfactory GERD control improved from 31.1% at baseline to
86.7% post-treatment. The GERD-HRQL is increasingly being
utilized to measure the QOL on morbidly obese patients,
however the psychological properties of this scale for these
specific patients need to be validated [11].
The GERD-HRQL is thought to be simple to use, easy to
understand and sensitive to treatment effects. The disad-
vantage of this scale is that it focuses on disease symptoms,
ignoring the importance of psychological status and social
function in QOL [3]. Therefore, this scale should be used in
conjunction with a generic questionnaire [12].
2.2. QOL questionnaire for GERD (GERD-QOL)
The GERD-QOL was developed by Chan et al. [3] in 2009 to
measure the impact of symptomatic GERD on QOL before and
after medical therapy. The original questionnaire of 30 items
was carefully reformulated leading to a new 18-item scale.
Removal of items with loadings 0.3 or lower and deletion of
arcane statements led to the generation of the final version of
the GERD-QOL questionnaire. This new scale consisted of 16
items clustered into the following four subscales: daily activ-
ity, treatment effect, diet and psychological well-being. The
total score of this questionnaire is the average of the four
subscale scores. The final score can range from 0 to 100, with a
higher score indicating a better QOL. The results of the psy-
chometric characteristic analysis of the GERD-QOL demon-
strated that the subscale scores were consistent between the
two visits (ICC 0.73e0.94, p < 0.001). The reliability coefficient
(Cronbach's a ¼ 0.64e0.88) was greater than 0.7 except for the
diet subscale. Pearson's correlation between the GERD-QOL
total score and the eight domains of the SF-36 was fair, but
significant (r ¼ 0.23e0.49, p < 0.001). Additionally, a significant
difference existed in GERD-QOL scores between baseline and
eight weeks post-esomeprazole treatment (p < 0.001) [3]. The
GERD-QOL scale was translated into English for broader use,
however further validation of this measurement tool needs to
be conducted with English-speaking patients. Furthermore,
the stability of this scale for multinational or multiethnic
studies still requires verification.
Two additional points should be considered when using
the GERD-QOL. First, it is important to consider that the
dimension of psychological well-being has only two items on
this scale, so special attention should be taken when inter-
preting this specific subscale score. Moreover, additional
studies should be performed on GERD patients with Barrett's
esophagus and the GERD-QOL, because this specific group of
patients was excluded in the development and validation of
this scale.
The GERD-QOL is a valid, reliable and acceptable scale for
respondents and is simple to administer in both clinical and
research contexts. This scale can be applied to patient pop-
ulations with wide age ranges and various educational levels.
Furthermore, with its multidimensional nature, the GERD-
QOL lacks the flaws of the GERD-HROL, which is more
focused on symptom severity [3]. Unfortunately, practical
application of the GERD-QOL is not ideal.
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In 1999, Raymond et al. [13] designed the Reflux-Qual ques-
tionnaire, which is a patient-centered, self-administered
postal questionnaire. The Reflux-Qual was developed to
evaluate the outcomes of GERD patients receiving surgery or
medical treatment in the randomized evaluation of laparo-
scopic surgery for reflux (REFLUX) trial. It was confirmed that
this questionnaire contained acceptable psychological prop-
erties with 37 items covering seven dimensions. Applying
multiple stepwise regression analysis, Raymond et al. [13]
showed that the QOL in GERD patients decreased with the
aggravation of severe endoscopic lesions, and increased
gradually when frequent symptoms declined. These results
demonstrate that the Reflux-Qual can determine factors that
influence QOL and provide prevention priorities for clinical
intervention. Another study [14] showed that the Reflux-Qual
can also be used for comparing differences in QOL between
GERD patients and other patients with diseases of the diges-
tive tract.
Since the Reflux-Qual contains 37 items, it was considered
to be cumbersome, time-consuming and inconvenient.
Therefore, Amouretti et al. [15] developed the revised short-
form reflux-qual (RQS), which is a short questionnaire based
on the Reflux-Qual. The RQS consists of eight items covering
four categories, including daily life, well-being, psychological
impact and sleeping/eating. A score ranging from 0 to 100,
with 100 representing the best health condition and zero the
worst health status, can be rapidly obtained using this ques-
tionnaire. The Cronbach's a coefficient of the RQS is 0.84 and
the response rate is 98.5%. Furthermore, the questionnaire
has the potential to determine both the improvement and
deterioration in patients' QOL for an entire study population.
Avaro et al. [16] investigated the QOL of 52 patients who un-
derwent GERD reoperation between 1986 and 2006. Either a
transthoracic or transabdominal operation was performed on
each patient. A telephone enquiry was completed using a
validated French RQS. The results verified that patients who
underwent transthoracic GERD surgery had the highest RQS
values, a lower complication rate and a lower rate of reoper-
ation. At present, the practicality of the RQS questionnaire has
been widely validated, and it has been utilized in several
different patient populations. Unfortunately, this question-
naire has yet to be translated into Chinese. In the future, the
RQS should be made available in Chinese and subsequently
validated in this language.
2.4. QOL questionnaire for patients undergoing anti-
reflux surgery (QOLARS)
Zeman et al. [17] designed the QOLARS scale to measure
satisfaction and other aspects of daily life for patients un-
dergoing anti-reflux surgery. The researchers combined the
European organization of research and treatment of cancer
(EORTC) QOL questionnaire (EORTC-QLQ-C30), the Visick
score and a modified GERD-HRQL to generate the QOLARS
questionnaire. When administered preoperatively, this ques-
tionnaire consists of 45 items. Five additional questions con-
cerning surgical complications and efficacy are includedwhen
the QOLARS is administered postoperatively. The total one-dimensional Cronbach's a coefficient of the QOLARS was
found to be 0.95, ranging from 0.74 to 96. Higher correlations
were found between scales for items measuring the conver-
gent validity, and lower correlations were found measuring
divergent validity. In 2007, Zeman and Tihanyi [18] required
patients to complete the QOLARS questionnaire before lapa-
roscopic anti-reflux surgery. The patients were also asked to
complete the questionnaire six weeks, one year and three
years post-surgery to analyze patient QOL and satisfaction.
The findings showed that the general QOL and heartburn
scores improved significantly within six weeks after surgery,
exhibited further improvement at the end of the first post-
operative year and then remained stable three years after
surgery. Importantly, this study also found that preoperative
QOL measurements can predict which patients will be satis-
fied with anti-reflux surgery.
A majority of items in the QOLARS questionnaire are spe-
cifically developed for patients undergoing anti-reflux sur-
gery. This questionnaire has a higher sensitivity and reliability
compared to other disease-specific scales and is more
descriptive of a patient's QOL. The QOLARS scale was
considered to bemore comprehensive than existingmeasures
when administrated to patients who had undergone laparo-
scopic fundoplication [18].
2.5. The GERD analyzer (GERDyzer)
The GERDyzer is a self-administered questionnaire primarily
designed to evaluate the impact of erosive GERD on QOL and
to assist medical staff in determining an optimal therapeutic
strategy [19]. The GERDyzer consists of 10 dimensions that can
be clustered into two factors based on factor analysis. To
calculate the total score of the GERDyzer, the first factor is
weighted by 1.0 and the second is weighted by 0.5. Holtmann
et al. [19] reported that they were able to obtain a consistently
high Cronbach's a coefficient of 0.95, a high test-retest reli-
ability demonstrated by an ICC of 0.91 and a responsiveness of
1.38. In Germany, Monnikes et al. [20] utilized the GERDyzer to
confirm the efficiency of Pantoprazole in relieving upper and
lower GI symptoms in patients with erosive esophagitis.
Another study [21] suggested that the GERDyzer could be
regarded as a standardized control to evaluate the psycho-
logical characteristics of new questionnaires.
The two biggest differences between the GERDyzer and
other GERD QOL questionnaires are the innovative design and
the content arrangement. Remarkably, the questionnaire
design, which utilizes graphics, seemingly improves response
rates and promotes nurse-patient communication. Unfortu-
nately, the complex scoring system and limited use of this
questionnaire has hindered the development and extension of
the GERDyzer. Future work should focus on expanding the use
and applicability of this scale.3. Hybrid QOL scales frequently utilized to
assess patients with GERD
Hybrid scales are appropriate for patients with any GI condi-
tion. The content of hybrid instruments not only includes GI
disease symptoms but also covers general health questions.
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are most often used in clinical work.
3.1. QOL questionnaire in reflux and dyspepsia
(QOLRAD)
Wiklund et al. [22] specifically designed the QOLRAD to eval-
uate the impact of GERD symptoms and dyspepsia on QOL.
Twenty-five questions are included in this scale and cover the
following five domains: emotions, vitality, sleep, eating/
drinking and physical/social functioning. The internal con-
sistency and discriminant validity were examined for the
QUOLRAD scale. A total Cronbach's a for the internal consis-
tency of the scale was reported as being >0.7 (overall a value of
0.97, dimensions 0.89e0.94), and the association between
similar constructs in the QOLRAD, the SF-36 and the GSRS
scores was confirmed. The QOLRAD is one of the most
commonly used hybrid scales in evaluating GERD, largely
because it addresses influence factors and the effect of clinical
treatment [23e25].
In China, Cao et al. [26] translated and revised the QOLRAD
and subsequently surveyed Chinese GERD patients. The re-
sults of this study showed that the total Cronbach's a coeffi-
cient of the QOLRAD is 0.98. In addition, a high testeretest
reliability was determined with an ICC ¼ 0.93. Moreover, the
researchers confirmed that all eight of the SF-36 dimensions
significantly correlated with the QOLRAD total score. The
research team also investigated the QOL status of GERD pa-
tients in Shanghai, China. These results revealed that GERD
patients have significantly more health problems than
healthy subjects of the same age, specifically in the areas of
eating disturbance, physical functions and emotional well-
being. In addition, they found that the severity of reflux
symptoms is closely related to physical comfort. To demon-
strate that the QOLRAD could be utilized as a discriminant
questionnaire to distinguish different populations, Niu and
colleagues [24] examined 256 patients with non-erosive reflux
disease whowere treatedwith the proton pump inhibitor (PPI)
esomeprazole. The patients were divided into symptom-free
and residual symptoms groups according to the QOLRAD
scale to analyze risk factors for refractoriness to PPIs. Thus,
the QOLRAD questionnaire can be routinely used as an eval-
uation tool for patients with GERD and dyspepsia.
3.2. The domestic/international gastroenterology
surveillance study questionnaire (DIGEST)
The DIGEST questionnaire was designed to investigate the
prevalence of upper GI symptoms in patients and the impact
these symptomshad onQOL. Eggleston et al. [27] reported that
the DIGEST questionnaire is primarily used as an epidemio-
logical investigational tool with satisfactory psychological
properties. The DIGEST questionnaire consists of two parts:
the first section is a newly developed instrument containing
27 questions and three dimensions (severity of disease, fre-
quency of symptoms and effect on daily activities), whereas
the second part is the PGWB, a validated generic QOL scale. A
survey of 5581 participants using the DIGEST questionnaire
demonstrated that heartburn, diarrhea and postprandial
abdominal distension are common GI symptoms. This studyalso found that sex, severity of symptoms and medical con-
dition correlate with the degree of impairment of health and
daily activities [27]. Tijssen [28] verified the external validity of
the DIGEST questionnaire and found that there were no sta-
tistically significant differences in age, sex and family income.
Therefore, this study can provide the theoretical basis for the
comparison of data from different geographical areas to show
that the DIGEST questionnaire can be used as a trans-regional,
indiscriminate survey.
Currently, the DIGEST questionnaire is primarily used for
large, multicenter, cross-sectional survey studies. Although
Meier et al. [5] reported that the DIGEST questionnaire could
be used as an index to evaluate the effect of drug tests, this
study was not in-depth. Therefore, the applicability of the
DIGEST scale in evaluating clinical intervention efficiency
needs to be verified.4. Conclusions
In summary, although a large variety of disease-specific QOL
questionnaires to assess patients with GERD are used world-
wide, there is still a lack of a recognized standard scale.
Importantly, research on QOL scales to evaluate Chinese pa-
tients with GERD is scarce compared to that in western
countries. Research onQOL assessment tools for patientswith
GERD is still at a very early stage in China, and reports in the
literature on QOL scales assessing GERD patients are rare.
Hence, future clinical studies need to develop an effective QOL
assessment tool for Chinese GERD patients undergoing med-
ical therapy.Conflict of interest
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